http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75b65e6c6160b4c4652131a25f8ea12d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Peyton |
| name | Michael Peyton |
| given-name | Michael |
| organization-name | Department of Pharmacology, Simmons Comprehensive Cancer Center, Department of Internal Medicine, Division of Translational Research, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 Authors' Affiliations: Departments of 1Thoracic/Head and Neck Medical Oncology, 2Biostatistics and Applied Mathematics, 3Translational Molecular Pathology, 4Diagnostic Imaging, 5Diagnostic Radiology, and 6Bioinformatics and Computational Biology; 7Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston; 8The Hamon Center for Therapeutic Oncology Research and Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas; 9Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Charlotte, North Carolina; 10Medical Oncology, Yale Cancer Center, New Haven, Connecticut; 11Division of Medical Oncology, University of Ottawa, Ottawa, Ontario; 12Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, Maryland; 13UC San Diego Moores Cancer Center, La Jolla, California; and 14Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Ly 3Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas. 6Hamon Center for Therapeutic Oncology Research and Simmons Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas. 3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas; Hamon Center for Therapeutic Oncology Research and Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390 Authors' Affiliations: Departments of 1Thoracic/Head and Neck Medical Oncology, 2Bioinformatics and Computational Biology, 3Pathology, 4Radiation Oncology, 5Systems Biology, and 6Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston; and 7Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern, Dallas, Texas 6Harold Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas 3 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA, Departments of Anesthesiology, Biological Chemistry, and Physiology, School of Medicine, and Institutes of Molecular Biology and Brain Research, University of California, Los Angeles, CA 90095 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030 1Hamon Center for Therapeutic Oncology Research and Departments of 2Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas. 2Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas. Departments of Anesthesiology, Biological Chemistry, Molecular, Cell and Developmental Biology, and Psychology, and the Brain Research and Molecular Biology Institutes, University of California, Los Angeles, CA 90095; and Department of Cell Biology, Baylor College of Medicine, Houston, TX 77030 Authors' Affiliations: 1Hamon Center for Therapeutic Oncology Research and the Simmons Cancer Center; Departments of 2Pharmacology, 3Clinical Sciences, 4Pathology, and 5Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas; and 6Department of Medicine and Molecular Science, Gunma University School of Medicine, Maebashi, Gunma, Japan Primary Care Sports Medicine, Agoura Hills, CA, USA 9Hamon Center for Therapeutic Oncology Research, and Departments of Authors' Affiliations: Departments of 1Thoracic and Head and Neck Medical Oncology, 2Bioinformatics and Computational Biology, 3Biostatistics, 4Radiation Oncology, 5Systems Biology, 6Pathology, 7Cancer Biology, and 8Experimental Therapeutics, and 9Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston; 10Hamon Center for Therapeutic Oncology Research and Simmons Cancer Center, University of Texas Southwestern, Dallas, Texas; 11Tolero Pharmaceuticals, Inc.; 12Astex Pharmaceuticals, Inc., Salt Lake City, Utah; and 13Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, USA 2Hamon Center for Therapeutic Oncology Research and Simmons Cancer Center, and Departments of Authors' Affiliations: 1Hamon Center for Therapeutic Oncology Research, 2Division of Translational Research, 3The Harold C. Simmons Comprehensive Cancer Center, and Departments of 4Internal Medicine, 5Pharmacology, and 6Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas; Departments of 7Pathology, 8Cancer Biology, and 9Molecular Therapeutics, M.D. Anderson Cancer Center, Houston, Texas; 10Department of Pathology, Stanford University Medical Center, Stanford, California; and 11Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, Florida Authors' Affiliations: Divisions of 1Hematology-Oncology, 2Pediatric Hematology-Oncology, 3Surgical Oncology, and the 4Hamon Center for Therapeutic Oncology Research, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; 5ImClone Systems, New York, New York Authors' Affiliations: 1Hamon Center for Therapeutic Oncology Research; Departments of 2Pharmacology, 3Internal Medicine, 4Clinical Sciences, and 5Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center; 6Joyant Pharmaceuticals Inc., Dallas, Texas; 7Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 8Zhongguancun Life Science Park, Beijing, China Departments of Anesthesiology; Biological Chemistry; Molecular, Cell and Developmental Biology; and Molecular Biology and Brain Research Institutes, University of California, Los Angeles, CA 90095; and Neurobiotechnology Institute, Ohio State University, Columbus, OH 43210 Authors' Affiliations: Departments of 1Thoracic and Cardiovascular Surgery and 2Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; and 3Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center; Dallas, Texas |
Incoming Links
Total number of triples: 92.